Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?-Reference-Cited by-同舟云学术

Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?

Published:2020-10-01 Issue:2 Volume:44 Page:254-260
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Elsayed Mohammad^ORCID,Cheng Bernard,Xing Minzhi,Sethi Ila,Brandon David,Schuster David M.,Bercu Zachary,Galt James,Barron Bruce,Kokabi Nima

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00270-020-02638-8.pdf

Reference25 articles.

1. Camacho JC, Moncayo V, Kokabi N, Reavey HE, Galt JR, Yamada K, et al. 90Y radioembolization: multimodality imaging pattern approach with angiographic correlation for optimized target therapy delivery. RadioGraphics. 2015;35(5):1602–18. https://doi.org/10.1148/rg.2015140314.

2. Bhangoo MS, Karnani DR, Hein PN, Giap H, Knowles H, Issa C, et al. Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma. J Gastrointest Oncol. 2015;6(5):469–78. https://doi.org/10.3978/j.issn.2078-6891.2015.056.

3. Gordon AC, Gabr A, Riaz A, Uddin OM, Abouchaleh N, Ali R, et al. Radioembolization super survivors: extended survival in non-operative hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2018;41(10):1557–655. https://doi.org/10.1007/s00270-018-2008-y.

4. Wehrenberg-Klee E, Gandhi RT, Ganguli S. Patient selection and clinical outcomes of Y90 in hepatocellular carcinoma. Tech Vasc Intervent Radiol. 2019;22(2):70–3. https://doi.org/10.1053/j.tvir.2019.02.006.

5. Kooby DA, Egnatashvili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J, et al. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. JVIR. 2010;21(2):224–30. https://doi.org/10.1016/j.jvir.2009.10.013.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on ⁹⁰Y Selective Internal Radiation Therapy Planning;Cancer Biotherapy and Radiopharmaceuticals;2024-06-01

2. An international phantom study of inter-site variability in Technetium-99m image quantification: analyses from the TARGET radioembolization study;EJNMMI Physics;2024-05-29

3. Implications of lung shunt fraction calculation discrepancy in Yttrium-90 radioembolization treatment from 2D planar vs 3D single photon emission CT imaging;BJR|Case Reports;2024-05-01

4. MIRD Pamphlet No. 29: MIRDy90—A⁹⁰Y Research Microsphere Dosimetry Tool;Journal of Nuclear Medicine;2024-02-22

5. Lung Mean Dose Prediction in Transarterial Radioembolization (TARE): Superiority of [166Ho]-Scout Over [99mTc]MAA in a Prospective Cohort Study;CardioVascular and Interventional Radiology;2024-02-07